Vacv

Developer of immuno-therapeutics for cancer treatment

placeLondon, England, United Kingdom calendar_todayFounded 2022 groups6 employees language vacvbtx.com

Registered entities

Investor mix

1 investor on record; lead investors include Proxima Ventures.

Investor typeCountShare
Private equity1100%
Coming soon